Clinical Trial Update: Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating short-course anti-tuberculosis regimens for mild spinal tuberculosis, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Tuberculosis

Snippet

Sponsor: Shandong University | Conditions: Mild Spinal Tuberculosis | Phase 2 | Status: NOT_YET_RECRUITING